4//SEC Filing
MEDNAX, INC. 4
Accession 0001209191-17-037318
$MDCIK 0000893949operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:42 PM ET
Size
6.1 KB
Accession
0001209191-17-037318
Insider Transaction Report
Form 4
Lopez-Blanco Vivian
Chief Financial Officer
Transactions
- Award
Common Stock
2017-06-01+23,365→ 71,125.24 total
Footnotes (2)
- [F1]Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 5,841 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2017 through March 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.
- [F2]Reflects a reduction of 3,559 in previously reported target shares that were granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement of specified performance-based criteria below target for the performance period from April 1, 2016 through March 31, 2017. The decrease in restricted shares impacts the installments vesting on June 1, 2017, June 1, 2018 and June 1, 2019. The vesting of such shares remains subject to continued employment.
Documents
Issuer
MEDNAX, INC.
CIK 0000893949
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0000893949
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:42 PM ET
- Size
- 6.1 KB